
Mole Bioscience
墨卓生物
Mole Bioscience
Biotech/Healthcare
MobiDrop was founded at Harvard University in 2018. Centered on microfluidic chip technology and proprietary genetic testing innovations, the company provides integrated solutions spanning the R&D, manufacturing, and sales of instruments, chips, reagents, and bioinformatics software.
Latest round: Pre Series B (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.